Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in COPD exacerbation
ISRCTN66148745Phase 4Completed
- Sponsor
- St George's, University of London
- Start
- Jan 2011
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Metformin with Placebo (2 arms). Primary endpoint: Mean capillary glucose concentration. Started Jan 2011; status: completed.
02
Drugs
metformin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ISRCTN66148745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN66148745.